Literature DB >> 29504544

Circular Inference in Dementia Diagnostics.

Poul F Høilund-Carlsen1,2, Jorge R Barrio3, Albert Gjedde1,2,4, Thomas J Werner5, Abass Alavi5.   

Abstract

Referring to recent international articles stating that amyloid imaging or detection has a high additive value in making a diagnosis of Alzheimer's disease (AD) when previous investigations are inconclusive, the authors of this editorial argue that this statement is based on circular reasoning and, hence, misleading. Since autopsy findings and other potential indicators fit poorly with amyloid PET, they conclude that this examination has no role in the diagnosis of AD.

Entities:  

Keywords:  Alzheimer’s disease; amyloid PET; circular inference; dementia

Mesh:

Substances:

Year:  2018        PMID: 29504544     DOI: 10.3233/JAD-180050

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  5 in total

1.  Suboptimal validity of amyloid imaging-based diagnosis and management of Alzheimer's disease: why it is time to abandon the approach.

Authors:  Abass Alavi; Jorge R Barrio; Thomas J Werner; Mohsen Khosravi; Andrew Newberg; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-02       Impact factor: 9.236

2.  An update on the unparalleled impact of FDG-PET imaging on the day-to-day practice of medicine with emphasis on management of infectious/inflammatory disorders.

Authors:  Abass Alavi; Søren Hess; Thomas J Werner; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-09-04       Impact factor: 9.236

3.  Aducanumab-Related Amyloid-Related Imaging Abnormalities: Paean or Lament?

Authors:  Poul F Høilund-Carlsen; Thomas J Werner; Abass Alavi; Mona-Elisabeth Revheim
Journal:  Clin Nucl Med       Date:  2022-04-22       Impact factor: 10.782

Review 4.  Cerebral glucose metabolic prediction from amnestic mild cognitive impairment to Alzheimer's dementia: a meta-analysis.

Authors:  Hai Rong Ma; Li Qin Sheng; Ping Lei Pan; Gen Di Wang; Rong Luo; Hai Cun Shi; Zhen Yu Dai; Jian Guo Zhong
Journal:  Transl Neurodegener       Date:  2018-04-23       Impact factor: 8.014

5.  A Cost-Consequence Analysis of Different Screening Procedures in Alzheimer's Disease: Results from the MOPEAD Project.

Authors:  Anders Wimo; Mark Belger; Jaka Bon; Frank Jessen; Annette Dumas; Milica G Kramberger; Laura Jamilis; Gunilla Johansson; Adrián Rodrigo Salas; Octavio Rodríguez Gómez; Lena Sannemann; Malou Stoekenbroek; Miren Gurruchaga Telleria; Sergi Valero; Lisa Vermunt; Lisa Waterink; Bengt Winblad; Peter Jelle Visser; Marissa Zwan; Mercè Boada
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.